Insuficiência venosa crônica e uso de meia elástica de compressão graduada: uma análise sobre a adesão ao tratamento em pacientes do SUS

Coral, Francisco Eduardo; Guarinello, Giovanna Golin; Cavassola, Alice Pavanatto; Rocha, Ana Luiza Moraes; Guidi, Marina Mosele; Pires, Hudson

doi:10.1590/1677-5449.200034

Cited by 6 publications

(13 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A reminder of the importance of wearing compression stockings was given by the practitioner during the preoperative consultation as well as after the procedure to encourage compliance. In addition, the procedures were not performed during the summer months, as the heat is an important factor in non-adherence [19].…”

Section: Discussionmentioning

confidence: 99%

Cyanoacrylate Glue for Treating Chronic Saphenous Vein Insufficiency: A Retrospective Observational Single-Center Study

Falvo¹,

Latreche²,

Chevallier³

et al. 2023

Preprint

View full text Add to dashboard Cite

Endovenous thermal methods are superseding surgical stripping for treating chronic superficial venous disease but require tumescent anesthesia and can cause heat-related nerve injuries. Endovenous cyanoacrylate ablation is a more recent technique that does not share these drawbacks. Retrospective observational study of consecutive adults managed with endovenous cyanoacrylate in 2018–2021 at a single university center. Follow-up was 18 months. We identified factors associated with target vein closure at 18 months and measured changes in quality of life using the generic 36-item Short-Form tool (SF-36) and the venous disease-specific VEINES-QOL/Sym questionnaire. Adverse events were collected. In the 55 study patients with 67 treated veins, the closure rate at 18 months was 94% (95%CI, 85%–98%). Target vein diameter ≥9.5 mm had 81% sensitivity and 75% specificity for predicting recanalization. Both quality-of-life scores improved significantly (P&lt;0.001 for both). The only adverse event was a type IV allergic reaction to cyanoacrylate that resolved with corticosteroid and histamine-antagonist therapy. Endovenous cyanoacrylate ablation was highly effective and safe in experienced hands. Studies are warranted to determine whether changes in the protocol increase the closure rate in patients with target veins ≥9.5 mm in diameter.

show abstract

Section: Discussionmentioning

confidence: 99%

Cyanoacrylate Glue for Treating Chronic Saphenous Vein Insufficiency: A Retrospective Observational Single-Center Study

Falvo¹,

Latreche²,

Chevallier³

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…However, many studies did not use compression stockings. Adherence to this treatment is notoriously poor [19]. Whether prescribing compression stockings for a brief period after the procedure decreases the risk of venous thrombosis deserves evaluation.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Cyanoacrylate Glue for Treating Chronic Saphenous Vein Insufficiency: A Retrospective Observational Single-Center Study

Falvo¹,

Latreche²,

Chevallier³

et al. 2023

Diagnostics

View full text Add to dashboard Cite

Endovenous thermal methods are superseding surgical stripping for treating chronic superficial venous disease but require tumescent anesthesia and can cause heat-related nerve injuries. Endovenous cyanoacrylate ablation is a more recent technique that does not share these drawbacks. A retrospective observational study of consecutive adults managed with endovenous cyanoacrylate was conducted in 2018–2021 at a single university center. The follow-up was 18 months. We identified factors associated with target vein closure at 18 months and measured changes in quality of life using the generic 36-item Short-Form (SF-36) tool and the venous disease-specific VEINES-QOL/Sym questionnaire. Adverse events were collected. In the 55 study patients with 67 treated veins, the closure rate at 18 months was 94% (95% CI, 85–98%). Target vein diameter ≥9.5 mm had 81% sensitivity and 75% specificity for predicting recanalization. Quality-of-life scores improved significantly (p < 0.001 for both surveys). The only adverse event was a type IV allergic reaction to cyanoacrylate that was resolved with corticosteroid and histamine-antagonist therapy. Endovenous cyanoacrylate ablation was highly effective and is safe in experienced hands. Studies are warranted to determine whether changes in the protocol increase the closure rate in patients with target veins ≥9.5 mm in diameter.

show abstract

“…Of the included studies, 10 mentioned lack of health literacy as a contributing factor to non-compliance. 29,32,[34][35][36][38][39][40][41]46 This included, but was not limited to, poor understanding as to why they need to wear GCT,…”

Section: Health Literacymentioning

confidence: 99%

“…[29][30][31][32][33][36][37][38][39][40][41] In 64% of the included studies, female was the predominant sex that participated. 5,[29][30][31][32]34,36,41,42 One study did not record the sex. 39 The literature search revealed diverse reasons for non-compliance, with significant overlap between the studies.…”

Section: Study Outcomesmentioning

confidence: 99%

Investigating low rates of compliance to graduated compression therapy for chronic venous insufficiency: A systematic review

Stevenson,

Coda,

Bourke

2024

International Wound Journal

View full text Add to dashboard Cite

Chronic venous insufficiency (CVI) is a chronic lower limb progressive disorder with significant burden. Graduated compression therapy is the gold‐standard treatment, but its underutilisation, as indicated in recent literature, may be contributing to the growing burden of CVI. The aim of this systematic review is to determine the reasons for poor compliance in patients who are prescribed graduated compression therapy in the management of chronic venous insufficiency. A systematic review of the literature was conducted to identify the reasons for non‐compliance in wearing graduated compression therapy in the management of chronic venous insufficiency. The keyword search was conducted through Medline, PubMed, CINAHL, Cochrane library, AMED, and Embase databases from 2000 to April 2023. Qualitative and quantitative studies were included with no study design or language limits imposed on the search. The study populations were restricted to adults aged over 18 years, diagnosed with chronic venous insufficiency. Of the 856 studies found, 80 full‐text articles were reviewed, with 14 being eligible for the review. Due to the variability in study designs, the results were summarised rather than subjected to meta‐analysis. There are five main overarching themes for non‐compliance, which are physical limitations, health literacy, discomfort, financial issues, and psychosocial issues with emerging sub‐themes. Graduated compression therapy has the potential to reduce the burden of chronic venous insufficiency if patients are more compliant with their prescription.

show abstract

Insuficiência venosa crônica e uso de meia elástica de compressão graduada: uma análise sobre a adesão ao tratamento em pacientes do SUS

Cited by 6 publications

References 9 publications

Cyanoacrylate Glue for Treating Chronic Saphenous Vein Insufficiency: A Retrospective Observational Single-Center Study

Cyanoacrylate Glue for Treating Chronic Saphenous Vein Insufficiency: A Retrospective Observational Single-Center Study

Cyanoacrylate Glue for Treating Chronic Saphenous Vein Insufficiency: A Retrospective Observational Single-Center Study

Investigating low rates of compliance to graduated compression therapy for chronic venous insufficiency: A systematic review

Contact Info

Product

Resources

About